{"id":94293,"date":"2026-08-17T09:16:07","date_gmt":"2026-08-17T13:16:07","guid":{"rendered":"https:\/\/bgodinspired.com\/?p=94293"},"modified":"2026-08-17T09:16:07","modified_gmt":"2026-08-17T13:16:07","slug":"new-alzheimers-discovery-grk2-compound-10","status":"publish","type":"post","link":"https:\/\/bgodinspired.com\/index.php\/bgodinspired-news\/bgodinspired-health-news\/new-alzheimers-discovery-grk2-compound-10\/","title":{"rendered":"New Alzheimer’s Discovery Reveals a Hidden Root Cause"},"content":{"rendered":"
\n
\n \t<\/i> Read Time:<\/span>7 Minute, 13 Second <\/div>\n\n <\/div>

You know the moment. Not the diagnosis — before that. The moment you ask your mother the same question twice in ten minutes, or she asks you the same question, and something in your stomach drops before your brain has even finished naming why. Alzheimer’s doesn’t usually announce itself with a headline. It shows up in small repeats, years before anyone says the word out loud.<\/p>\n\n

For nearly three decades, the leading Alzheimer’s theory has centered on amyloid plaques — sticky protein clumps that build up between brain cells. Most of the drugs developed to treat the disease have been built to attack those plaques directly, and the results have been, at best, modest. This month, a research team in Switzerland published something that takes a different route entirely. They didn’t go after the plaques everyone already knew about. They went after a protein that was sitting in plain sight the whole time — and in mice, stopping it did something the plaque-targeting drugs haven’t managed to do.<\/p>\n\n

The Enzyme Nobody Was Watching<\/h2>\n\n

The protein is called GRK2 — short for G protein-coupled receptor kinase 2 — and under normal conditions, it’s an ordinary, useful part of how your cells communicate. It exists in two forms, active and inactive, the way a light switch exists in two positions. Researchers led by Professor Ursula Quitterer at ETH Zurich found something nobody had connected before: in the brains of people with dementia, unusually large amounts of the inactive<\/em> form of GRK2 build up and clump together inside brain cells.<\/p>\n\n

Those clumps aren’t passive. They physically block mitochondria — the tiny structures that generate a cell’s energy — from doing their job properly. Starve a neuron’s power supply long enough, and it also starts producing more amyloid-beta, the very protein everyone else has been targeting for thirty years. In other words: the plaques a lot of Alzheimer’s research chases may be partly downstream of a completely different, quieter problem. The team’s findings were published in Cell Reports Medicine<\/em> in 2026.<\/p>\n\n